Both in Pharmaceuticals
IGC Pharma vs TransCode Therapeutics
Over the past year IGC returned −36.3% and RNAZ returned −84.7%; their daily moves had a correlation of 0.11.
IGC −36.3% RNAZ −84.7%Growth of $1, one year, split-adjusted
| Metric | IGC | RNAZ |
|---|---|---|
| Price | $0.2675 | $1.63 |
| Market cap | $27.7M | $27.6M |
| Today | −2.37% | −4.68% |
| 1 month | −13.7% | −25.2% |
| 6 months | +4.7% | −81.0% |
| Year to date | −4.9% | −76.1% |
| 1 year | −32.7% | — |
| Revenue growth (YoY) | −19.2% | — |
| Gross margin | 18.1% | — |
| Net margin | −1107.9% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$728.0K | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | 51.4% | 98.5% |
| Short % of float | 1.2% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).